Franklin Genomic Advancements ETF (HELX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HELX | ||||
| Company | Franklin Genomic Advancements ETF | ||||
| Price Information | |||||
| Exchange | NYSE Arca | ||||
| Open | 39.29 | ||||
| High | 39.29 | ||||
| Low | 38.70 | ||||
| Latest | 38.89 | ||||
| Change | -0.24 | ||||
| % Change | -0.60% | ||||
| Volume | 21,156 | ||||
| 20-Day Average Volume | 3,485 | ||||
| Previous Close | 39.13 | ||||
| Industry | N/A | ||||
| Has Options | Yes | ||||
| Technicals | |||||
| 20-Day Moving Average | 39.71 | ||||
| 20-Day Raw Stochastic | 15.07% | ||||
| 20-Day Relative Strength | 54.39 | ||||
| Weighted Alpha | +36.18 | ||||
| Today's Opinion | 72% Buy | ||||
| Previous Opinion | 72% Buy | ||||
| Last Month's Opinion | 72% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.38% since 07/22/26 | ||||
| Low | 38.69 on 07/29/26 | ||||
| High | 39.33 on 07/27/26 | ||||
| 1-Month | |||||
| %Chg | -2.87% since 06/29/26 | ||||
| Low | 38.46 on 07/20/26 | ||||
| High | 41.30 on 07/07/26 | ||||
| 3-Month | |||||
| %Chg | +19.41% since 04/29/26 | ||||
| Low | 32.39 on 05/18/26 | ||||
| High | 41.30 on 07/07/26 | ||||
| 6-Month | |||||
| %Chg | +5.60% since 01/29/26 | ||||
| Low | 31.24 on 03/27/26 | ||||
| High | 41.30 on 07/07/26 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 29,169 | ||||
| Shares Outstanding, K | 750 | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 0 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | 0.98 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Earnings Date | N/A | ||||
| Most Recent Dividend | 0.143 on 12/30/25 | ||||
| Next Ex-Dividends Date | 12/30/25 | ||||
| Ratios | |||||
| Price/Earnings ttm | 29.78 | ||||